TESTOSTERONE BASE 50
Description
Testosterone Base 50 (Testosterone Suspension injection, USP) provides non esterified Testosterone making it a “pure” version of the parent hormone, Testosterone. Therefore, there is no ester to be accounted for in the weight. This means 100 mg of testosterone suspension contains 100 mg of the steroid. This makes it the most potent forms of Testosterone available. Gains come quicker and side effects much more possible with such a strong version of this hormone.
Because testosterone suspension does not need to break down an attached ester (like other esterified versions) the hormone is effective immediately when administered. The users testosterone levels will be raised for only 2-3 days (at most) after injection and the steroid should be administered daily. This testosterone is dissolved in water typically, not oil like most of the other esterified versions making it more readily available in the body.
Details
- Test – Base 50 – Testosterone Suspension USP
- Aqueous
- presented as 10 x 1 ml ampoules per box (50mg/ml)
Clinical pharmacology
Endogenous androgens such as testosterone are responsible for the development and growth of the male sexual organs and post-adolescent secondary sex characteristics. Androgen effects include but are not limited to the maturation of the penis, scrotum, prostate, seminal tubules, laryngeal enlargement, vocal cord thickening, changes in muscle mass and fat distribution, and the development and distribution of male hair (facial, pubic, chest, back, axillary).
Androgens have been linked to increased protein anabolism and consequent decreased protein catabolism.
Androgens increase retention of sodium, potassium, and phosphorus. Androgens decrease urinary excretion of calcium.
Androgens are responsible for the growth spurt of adolescence and the aromatization of androgens to estrogens for the eventual termination of linear growth, which is brought about by fusion of the epiphyseal growth centers. In children, exogenous androgens accelerate linear growth rates but may cause a disproportionate advancement in bone maturation. Use over long periods may result in fusion of the epiphyseal growth centers and termination of the growth process. Androgens have been reported to stimulate the production of red blood cells by enhancing the production of erythropoietin stimulating factor.
Androgens may suppress gonadotrophic function of the pituitary. During exogenous administration of androgens, endogenous testosterone release is inhibited through feedback inhibition of pituitary luteinizing hormone (LH). With large doses, spermatogenesis may be suppressed through feedback inhibition of pituitary follicle stimulating hormone (FSH).